Ma F, Li Q, Chen S, Zhu W, Fan Y, Wang J, Luo Y, Xing P, Lan B, Li M, et al. Phase I study and biomarker analysis of pyrotinib, a novel irreversible pan-ErbB receptor tyrosine kinase inhibitor, in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. J Clin Oncol. 2017;35(27):3105–12.
Article
CAS
Google Scholar
Ma F, Ouyang Q, Li W, Jiang Z, Tong Z, Liu Y, Li H, Yu S, Feng J, Wang S, et al. Pyrotinib or lapatinib combined with capecitabine in HER2-positive metastatic breast cancer with prior taxanes, anthracyclines, and/or trastuzumab: a randomized phase II study. J Clin Oncol. 2019;37(29):2610–9.
Article
CAS
Google Scholar
Xu B, Yan M, Ma F, Hu X, Feng J, Ouyang Q, Tong Z, Li H, Zhang Q, Sun T, et al. Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet Oncol. 2021;22(3):351–60.
Article
CAS
Google Scholar
Zhou C, Li X, Wang Q, Gao G, Zhang Y, Chen J, Shu Y, Hu Y, Fan Y, Fang J, et al. Pyrotinib in HER2-mutant advanced lung adenocarcinoma after platinum-based chemotherapy: a multicenter, open-label, single-arm phase II study. J Clin Oncol. 2020;38(24):2753–61.
Article
CAS
Google Scholar
Yang G, Hao X, Hu J, Dong K, Xu H, Yang L, Zhang S, Yang Y, Xu F. Pyrotinib in HER2 heterogeneously mutated or amplified advanced non-small cell lung cancer patients: a retrospective real-world study (PEARL). J Nat Cancer Cent. 2021;1(4):139–46.
Article
Google Scholar
Di Fiore F, Van Cutsem E. Acute and long-term gastrointestinal consequences of chemotherapy. Best Pract Res Clin Gastroenterol. 2009;23(1):113–24.
Article
Google Scholar
Stein A, Voigt W, Jordan K. Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol. 2010;2(1):51–63.
Article
CAS
Google Scholar
Yang M, Hong G, Jin Y, Li Y, Li G, Hou X. Mucosal-associated microbiota other than luminal microbiota has a close relationship with diarrhea-predominant irritable bowel syndrome. Front Cell Infect Microbiol. 2020;10:515614.
Article
CAS
Google Scholar
Zhuang X, Tian Z, Li L, Zeng Z, Chen M, Xiong L. Fecal microbiota alterations associated with diarrhea-predominant irritable bowel syndrome. Front Microbiol. 2018;9:1600.
Article
Google Scholar
Berkes J, Viswanathan VK, Savkovic SD, Hecht G. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut. 2003;52(3):439–51.
Article
CAS
Google Scholar
Negoro S, Shimohata T, Hatayama S, Sato Y, Matsumoto M, Iba H, Aihara M, Uebanso T, Hamada Y, Nishikawa Y, et al. Campylobacter jejuni infection suppressed Cl(-) secretion induced by CFTR activation in T-84 cells. J Infect Chemother. 2014;20(11):682–8.
Article
CAS
Google Scholar
Krautkramer KA, Fan J, Backhed F. Gut microbial metabolites as multi-kingdom intermediates. Nat Rev Microbiol. 2021;19(2):77–94.
Article
CAS
Google Scholar
Nicholson JK, Wilson ID. Opinion: understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov. 2003;2(8):668–76.
Article
CAS
Google Scholar
Feng W, Ao H, Peng C, Yan D. Gut microbiota, a new frontier to understand traditional Chinese medicines. Pharmacol Res. 2019;142:176–91.
Article
CAS
Google Scholar
He WJ, Cao DM, Chen YB, Shi JJ, Hu T, Zhang ZT, Lan T, Tang D, Wang SM. Explore of the beneficial effects of Huang-Lian-Jie-Du decoction on diabetic encephalopathy in db/db mice by UPLC-Q-Orbitrap HRMS/MS based untargeted metabolomics analysis. J Pharm Biomed Anal. 2021;192:113652.
Article
CAS
Google Scholar
Zhao J, Tian S, Lu D, Yang J, Zeng H, Zhang F, Tu D, Ge G, Zheng Y, Shi T, et al. Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19. Phytomedicine. 2021;85:153315.
Article
CAS
Google Scholar
Xu W, Zhang Y, Yu Y, Li B, Liu J, Wang P, Wu H, Liu Q, Wei Z, Xiao H, et al. Dose-dependent target diversion of Danhong injection on the Glu-GLT-1/Gly-GlyRalpha dynamic balance module of cerebral ischemia. Pharmacol Res. 2018;135:80–8.
Article
CAS
Google Scholar
House SPCJBPsMP. Pharmacopoeia of the People’s Republic of China. 2010.
Part NPCJ. Pharmacopoeia of the People’s Republic of China. 2015;1:188-189.
Ma Q, Ouyang Y, Meng F, Noolvi MN, Avvaru SP, More UA, Aminabhavi TM, Du M, Liu H, Zhuang Y, et al. A review of pharmacological and clinical studies on the application of Shenling Baizhu San in treatment of Ulcerative colitis. J Ethnopharmacol. 2019;244:112105.
Article
CAS
Google Scholar
Xiao Y, Zhang K, Zhu SY, Deng XL, Chen XY, Fu NL, Chen J. Shenling Baizhu powder () ameliorates pi (Spleen)-deficiency-induced functional diarrhea in rats. Chin J Integr Med. 2021;27(3):206–11.
Article
CAS
Google Scholar
Feng-Zhen LI, Cui TB. Analysis on adverse reactions of Chinese medicine targeted drugs. J Liaoning Univ Tradit Chin Med. 2012.
Liu C, Zhu Q. Study on HPLC characteristic fingerprint of Shenlingbaizhu powder and simultaneous determination of its five indicative components. QJCP. 2018;27:12.
Google Scholar
Bowen JM, Mayo BJ, Plews E, Bateman E, Stringer AM, Boyle FM, Finnie JW, Keefe DM. Development of a rat model of oral small molecule receptor tyrosine kinase inhibitor-induced diarrhea. Cancer Biol Ther. 2012;13(13):1269–75.
Article
CAS
Google Scholar
Ji HJ, Kang N, Chen T, Lv L, Ma XX, Wang FY, Tang XD. Shen-ling-bai-zhu-san, a spleen-tonifying Chinese herbal formula, alleviates lactose-induced chronic diarrhea in rats. J Ethnopharmacol. 2019;231:355–62.
Article
Google Scholar
Subik K, Lee JF, Baxter L, Strzepek T, Costello D, Crowley P, Xing L, Hung MC, Bonfiglio T, Hicks DG, et al. The expression patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines. Breast Cancer (Auckl). 2010;4:35–41.
Google Scholar
Singh SS, Mattheolabakis G, Gu X, Withers S, Dahal A, Jois S. A grafted peptidomimetic for EGFR heterodimerization inhibition: Implications in NSCLC models. Eur J Med Chem. 2021;216:113312.
Article
CAS
Google Scholar
Ding H, Yi X, Zhang X, Wang H, Liu H, Mou WW. Imbalance in the gut microbiota of children with autism spectrum disorders. Front Cell Infect Microbiol. 2021;11:572752.
Article
CAS
Google Scholar
Gao K, Yang R, Zhang J, Wang Z, Jia C, Zhang F, Li S, Wang J, Murtaza G, Xie H, et al. Effects of Qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology. Pharmacol Res. 2018;130:93–109.
Article
Google Scholar
Zhang F, Li Y, Wang X, Wang S, Bi D. The impact of lactobacillus plantarum on the gut microbiota of mice with DSS-induced colitis. Biomed Res Int. 2019;2019:3921315.
Google Scholar
Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M, Gauthier C, Jacques PE, Li S, Xia J. MetaboAnalyst 50: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 2021;49(W1):W388–96.
Article
CAS
Google Scholar
Feng YL, Cao G, Chen DQ, Vaziri ND, Chen L, Zhang J, Wang M, Guo Y, Zhao YY. Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease. Cell Mol Life Sci. 2019;76(24):4961–78.
Article
CAS
Google Scholar
He D, Huang JH, Zhang ZY, Du Q, Peng WJ, Yu R, Zhang SF, Zhang SH, Qin YH. A network pharmacology-based strategy for predicting active ingredients and potential targets of LiuWei DiHuang Pill in treating type 2 diabetes mellitus. Drug Des Devel Ther. 2019;13:3989–4005.
Article
CAS
Google Scholar
Inatomi T, Honma M. Effects of probiotics on loperamide-induced constipation in rats. Sci Rep. 2021;11(1):24098.
Article
CAS
Google Scholar
Zhang Y, Tang K, Deng Y, Chen R, Liang S, Xie H, He Y, Chen Y, Yang Q. Effects of Shenling Baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats. Biomed Pharmacother. 2018;102:1025–36.
Article
Google Scholar
Gong X, Li X, Bo A, Shi RY, Li QY, Lei LJ, Zhang L, Li MH. The interactions between gut microbiota and bioactive ingredients of traditional Chinese medicines: a review. Pharmacol Res. 2020;157:104824.
Article
CAS
Google Scholar
Guo H, Chou WC, Lai Y, Liang K, Tam JW, Brickey WJ, Chen L, Montgomery ND, Li X, Bohannon LM, et al. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites. Science. 2020.370(6516):eaay9097.
Article
Google Scholar
Riva A, Kuzyk O, Forsberg E, Siuzdak G, Pfann C, Herbold C, Daims H, Loy A, Warth B, Berry D. A fiber-deprived diet disturbs the fine-scale spatial architecture of the murine colon microbiome. Nat Commun. 2019;10(1):4366.
Article
Google Scholar
Yan F, Polk DB. Probiotics and immune health. Curr Opin Gastroenterol. 2011;27(6):496–501.
Article
Google Scholar
Zou YT, Zhou J, Wu CY, Zhang W, Shen H, Xu JD, Zhang YQ, Long F, Li SL. Protective effects of Poria cocos and its components against cisplatin-induced intestinal injury. J Ethnopharmacol. 2021;269:113722.
Article
CAS
Google Scholar
Qu L, Shi K, Xu J, Liu C, Ke C, Zhan X, Xu K, Liu Y. Atractylenolide-1 targets SPHK1 and B4GALT2 to regulate intestinal metabolism and flora composition to improve inflammation in mice with colitis. Phytomedicine. 2022;98:153945.
Article
CAS
Google Scholar
Sun Y, Liu T, Si Y, Cao B, Zhang Y, Zheng X, Feng W. Integrated metabolomics and 16S rRNA sequencing to investigate the regulation of Chinese yam on antibiotic-induced intestinal dysbiosis in rats. Artif Cells Nanomed Biotechnol. 2019;47(1):3382–90.
Article
CAS
Google Scholar
Trindade BC, Ceglia S, Berthelette A, Raso F, Howley K, Muppidi JR, Reboldi A. The cholesterol metabolite 25-hydroxycholesterol restrains the transcriptional regulator SREBP2 and limits intestinal IgA plasma cell differentiation. Immunity. 2021;54(10):2273-87 e2276.
Article
Google Scholar
Hwang TC, Yeh JT, Zhang J, Yu YC, Yeh HI, Destefano S. Structural mechanisms of CFTR function and dysfunction. J Gen Physiol. 2018;150(4):539–70.
Article
CAS
Google Scholar
Staley C, Weingarden AR, Khoruts A, Sadowsky MJ. Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Appl Microbiol Biotechnol. 2017;101(1):47–64.
Article
CAS
Google Scholar
Wahlstrom A, Sayin SI, Marschall HU, Backhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41–50.
Article
Google Scholar
Guzior DV, Quinn RA. Review: microbial transformations of human bile acids. Microbiome. 2021;9(1):140.
Article
CAS
Google Scholar
Shao J, Liu Y, Wang H, Luo Y, Chen L. An integrated fecal microbiome and metabolomics in T2DM rats reveal antidiabetes effects from host-microbial metabolic axis of EtOAc extract from sophora flavescens. Oxid Med Cell Longev. 2020;2020:1805418.
Article
Google Scholar
Tang K, Hao W, Mo X, Chen Y, Guo X, He L, Wang B, Wang J, Ma Q, Deng L, et al. Analysis of the therapeutic effect of Dimu Ningshen (TCM formula) on attention deficit hyperactivity disorder based on gut microbiota and serum metabolomics. BMC Complement Med Ther. 2022;22(1):24.
Article
CAS
Google Scholar
Liu R, Peng C, Jing D, Xiao Y, Zhu W, Zhao S, Zhang J, Chen X, Li J. Lachnospira is a signature of antihistamine efficacy in chronic spontaneous urticaria. Exp Dermatol. 2022;31(2):242–7.
Article
CAS
Google Scholar
Ren Z, Wang X, Wang S, Zhai C, He Y, Zhang Y, Qiao Y. Mechanism of action of salvianolic acid B by module-based network analysis. Biomed Mater Eng. 2014;24(1):1333–40.
CAS
Google Scholar